PRINCIPAL INVESTIGATORS:
DR. ASHRAF AMINORROAYA
Professor of Endocrinology
Faculty of Medicine
Isfahan University of Medical Sciences
&
DR. MASOUD AMINI
Professor of Endocrinology
Faculty of Medicine
Isfahan University of Medical Sciences
Isfahan Endocrine and Metabolism Research Center, Isfahan University of Medical Sciences, Isfahan. Iran. Isfahan. Khorram Street Complex Research Center of Sedigheh Tahereh. Ground Floor. Isfahan Endocrine and Metabolism Research Center.
Approval date
2004
Starting date
2006
Goals
– To determine the prevalence and incidence of overt and subclinical hypothyroidism, overt and subclinical hyperthyroidism, thyroid nodule, goiter and thyroid autoimmunity and iodine status by sex, age, parity, menopause, smoking habbit and … in Isfahan city. – To determine the value and power of thyroid autoantibodies, age, BMI, FPG, positive family history of thyroid diseases, history of smoking, abortion and age at menopause for prediction of occurrence of above-mentioned thyroid disorders. – To determine the reference range for T3, T4, TSH and T3RU by sex and age groups
Study population
Adult population of Isfahan City (age>20 years)
Sampling method and sample size
Cluster sampling 3000 people
Data Collection
– Enrolment of adult population of Isfahan city by cluster sampling of families – Data collection forms about age, sex, history of thyroid disease, drug history, parity, abortions, age at menopause, smoking, – Clinical and ultrasonographic examination for goiter, thyroid nodules – Measurement of TSH, T4, T3, T3RU or TSH if indicated FT4, thyroid autoantibodies including, TPOAb
Follow up Methods
-First phase: 2006 -Second phase: 2011 -Third phase: 1398 -5 to 10- year interval follow up forever by recalls and repeating the protocol for euthyroid people
Main Exposures
Demographic, anthropometric measurements, age of menopause, number of parity and abortions, past history of thyroid disorders and smoking, use of medications, especially drugs that interfere with thyroid function, and the past medical history
Outcomes
Overt and subclinical hypothyroidism, overt and subclinical hyperthyroidism, thyroid nodule, goiter and thyroid autoimmuity, iodine deficiency or excess